Acceleron Pharma Inc (XLRN)

116.52 -3.49  -2.91% NASDAQ Dec 2, 16:59 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/26/2021 Earnings Acceleron Pharma Inc Fourth Quarter Earnings for 2020 Release
02/26/2021 17:00 EST Misc Acceleron Pharma Inc Fourth Quarter Earnings Conference Call for 2020
11/05/2020 Earnings Acceleron Pharma Inc Third Quarter Earnings Result for 2020
11/05/2020 17:00 EST Misc Acceleron Pharma Inc Third Quarter Earnings Conference Call for 2020
08/06/2020 17:00 EDT Misc Acceleron Pharma Inc Second Quarter Earnings Conference Call for 2020
08/06/2020 Earnings Acceleron Pharma Inc Second Quarter Earnings Result for 2020
06/04/2020 09:30 EDT Misc Acceleron Pharma Inc Annual General Meeting for 2019
05/11/2020 17:00 EDT Misc Acceleron Pharma Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Acceleron Pharma Inc First Quarter Earnings Result for 2020
02/27/2020 17:00 EST Misc Acceleron Pharma Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.acceleronpharma.com
  • Investor Relations URL: http://investor.acceleronpharma.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 26, 2021
  • Last Earnings Release: Nov. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. Acceleron generates its revenue through collaboration, licensing, and research arrangements with collaboration partners for the development and commercialization of therapeutic candidates. The company sometimes uses contract research organizations and research institutions outside the United States.

Top Fund Holders

Symbol Name Weighting
SBIO ALPS Medical Breakthroughs ETF 4.36%
BGLUX Baron Global Advantage R6 3.23%
PBE Invesco Dynamic Biotech & Genome ETF 3.08%
BBP Virtus LifeSci Biotech Products ETF 2.74%
FTHI First Trust BuyWrite Income ETF 2.60%
FBIOX Fidelity® Select Biotechnology 2.36%
FPHAX Fidelity® Select Pharmaceuticals Port 2.24%
FIJYX Fidelity Advisor® Biotechnology Z 1.83%
CEARX Columbia Acorn Adv 1.70%
PHSRX Putnam Global Health Care R 1.40%
BMEZ BlackRock Health Sciences Trust II 1.19%
BTEC Principal Healthcare Innovators ETF 1.02%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.